PHARMACEUTICAL STATISTICS

Scope & Guideline

Bridging the Gap between Pharmacology and Statistical Excellence

Introduction

Welcome to your portal for understanding PHARMACEUTICAL STATISTICS, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1539-1604
PublisherWILEY
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2004 to 2024
AbbreviationPHARM STAT / Pharm. Stat.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The journal 'Pharmaceutical Statistics' is dedicated to the dissemination of innovative statistical methodologies and their applications in the pharmaceutical and clinical research fields. It focuses on enhancing the design, analysis, and interpretation of clinical trials and other biomedical studies through rigorous statistical frameworks.
  1. Innovative Statistical Methodologies:
    The journal emphasizes the development and application of novel statistical techniques tailored for clinical trials, including Bayesian methods, adaptive designs, and machine learning approaches.
  2. Clinical Trial Design and Analysis:
    A core focus is on optimizing clinical trial designs, such as multi-arm and multi-stage trials, to improve efficiency and decision-making in drug development.
  3. Pharmacokinetics and Pharmacodynamics:
    Research often includes the statistical analysis of pharmacokinetic and pharmacodynamic data, addressing how drugs affect the body and vice versa, which is critical in drug development.
  4. Real-World Evidence and Data Integration:
    The journal explores methodologies for integrating real-world data into clinical trial designs, enhancing the relevance and applicability of trial results in broader populations.
  5. Patient-Reported Outcomes and Quality of Life:
    It also covers statistical methods for analyzing patient-reported outcomes, focusing on how treatments impact patients' quality of life and their overall treatment experience.
The journal exhibits a dynamic evolution in its focus areas, with several emerging themes gaining traction in recent years. These trends highlight the journal's responsiveness to contemporary challenges in pharmaceutical research and statistics.
  1. Bayesian Adaptive Designs:
    There is a significant increase in research on Bayesian adaptive trial designs, which offer flexibility in modifying trial parameters based on interim results, thereby enhancing decision-making during clinical trials.
  2. Machine Learning Applications:
    The integration of machine learning techniques into statistical methodologies is on the rise, particularly for predicting treatment outcomes and analyzing complex datasets, reflecting the industry's push towards data-driven approaches.
  3. Real-World Evidence Utilization:
    The use of real-world evidence in clinical trial designs and post-marketing surveillance is becoming more prominent, emphasizing the need to understand how treatments perform in broader, more diverse patient populations.
  4. Patient-Centric Approaches:
    There is a growing emphasis on patient-centered methodologies, particularly in analyzing patient-reported outcomes and incorporating patient preferences into trial designs, which aligns with the broader movement towards personalized medicine.
  5. Hybrid Clinical Trials:
    Research on hybrid clinical trial designs that combine elements of traditional randomized controlled trials with real-world data is emerging, indicating a shift towards more innovative and adaptable research frameworks.

Declining or Waning

While 'Pharmaceutical Statistics' continues to thrive in various areas, certain themes appear to be losing prominence in recent publications. These declining scopes reflect shifts in research focus and methodological preferences within the field.
  1. Traditional Frequentist Approaches:
    There is a noticeable decline in the emphasis on traditional frequentist statistical methods. The growing preference for Bayesian approaches suggests a shift towards more flexible modeling frameworks that can incorporate prior information.
  2. Single-Endpoint Trials:
    Research focused solely on single endpoints in clinical trials is becoming less common, with a trend towards multi-endpoint designs that provide a more comprehensive evaluation of treatment effects.
  3. Basic Statistical Theory:
    Publications that delve deeply into basic statistical theory without direct application to practical problems are waning, as the field increasingly favors applied methodologies and real-world applications.
  4. Conventional Data Handling Techniques:
    The use of conventional data handling methods, such as simple imputation techniques, is decreasing in favor of more advanced approaches that address complexities in missing data and incorporate machine learning techniques.

Similar Journals

BIOSTATISTICS

Championing excellence in biostatistical research and application.
Publisher: OXFORD UNIV PRESSISSN: 1465-4644Frequency: 4 issues/year

BIOSTATISTICS is a premier academic journal dedicated to the intersection of statistical methodologies and their applications in the field of biomedicine, published by Oxford University Press. With its ISSN 1465-4644 and E-ISSN 1468-4357, the journal has established itself as a crucial resource for researchers and professionals in the broad disciplines of statistics and probability, particularly within medical contexts. The journal proudly holds a Q1 ranking in multiple categories as of 2023, including Medicine (miscellaneous), Statistics and Probability, as well as Statistics, Probability, and Uncertainty, placing it at the forefront of statistical research. It has also achieved notable Scopus rankings, underscoring its influence and reach—ranking 27th in Mathematics (Statistics and Probability) and 94th in Medicine (General Medicine). Although it does not currently offer open access options, BIOSTATISTICS remains committed to advancing scholarly conversation and innovation in statistical science, making it an essential outlet for both established and emerging researchers. With contributions spanning from 2003 to 2024, this journal is actively seeking to foster an understanding of complex statistical approaches in biomedicine, enabling professionals in the field to apply robust statistical techniques to real-world problems.

Korean Journal of Applied Statistics

Empowering Researchers with Rigorous Statistical Insights
Publisher: KOREAN STATISTICAL SOCISSN: 1225-066XFrequency: 6 issues/year

Korean Journal of Applied Statistics, published by the Korean Statistical Society, is a prominent journal dedicated to advancing the field of applied statistics. ISSN 1225-066X (Print) and E-ISSN 2383-5818 (Online), this journal serves as a vital platform for disseminating high-quality research that addresses the latest methodologies, applications, and innovations in statistical practices. Though currently not an open-access journal, it aims to foster collaboration among statisticians, researchers, and practitioners by providing rigorous peer-reviewed articles that enhance understanding and application of statistical techniques across various disciplines. With a commitment to integrating theory and practice, the Korean Journal of Applied Statistics stands as a crucial resource for those seeking to influence the evolving landscape of statistical research and its applications in Korea and beyond.

Statistics and Its Interface

Innovating Statistical Methods for Real-World Applications
Publisher: INT PRESS BOSTON, INCISSN: 1938-7989Frequency: 4 issues/year

Statistics and Its Interface, issn 1938-7989, published by INT PRESS BOSTON, INC, is a vital academic journal dedicated to bridging the critical intersection of statistics, applied mathematics, and interdisciplinary research. With its inaugural publication in 2011, this journal has continually aimed to provide a platform for innovative statistical methods and their application across various fields, offering valuable insights for researchers and practitioners alike. While the journal currently operates without an open access model, it maintains an essential position within the scholarly community, evidenced by its 2023 rankings in the third quartile for Applied Mathematics and the fourth quartile for Statistics and Probability. Furthermore, it holds a respectable position in Scopus rankings, reflecting its commitment to quality over quantity. By publishing cutting-edge research, Statistics and Its Interface serves as a critical resource for advancing statistical knowledge and cultivating a deeper understanding of its applications in real-world contexts.

STATISTICS

Nurturing quality research in statistics and probability.
Publisher: TAYLOR & FRANCIS LTDISSN: 0233-1888Frequency: 6 issues/year

STATISTICS is a distinguished journal published by Taylor & Francis Ltd, dedicated to advancing the field of statistical science since its inception in 1985. With a strong focus on both the theoretical and practical aspects of Statistics and Probability, this journal serves as a vital platform for researchers, professionals, and students seeking to disseminate their findings and contribute to critical discussions in the discipline. Although categorized in the Q3 quartile for both Statistics and Probability and Statistics, Probability and Uncertainty, the journal's commitment to quality research is evidenced by its inclusion in relevant Scopus rankings. It holds respectable positions, ranked #132/168 in Decision Sciences and #219/278 in Mathematics. By providing a venue for high-quality research articles and reviews, STATISTICS aims to foster innovation, reinforce methodological advancements, and address contemporary challenges in statistical applications. The journal does not currently offer open access, but it is widely distributed, ensuring that significant research reaches the communities that need it most. Researchers are encouraged to submit their work to this essential resource that continues to shape the landscape of statistical inquiry.

Electronic Journal of Applied Statistical Analysis

Elevating Standards in Statistical Research and Application
Publisher: UNIV STUDI SALENTOISSN: 2070-5948Frequency: 1 issue/year

Welcome to the Electronic Journal of Applied Statistical Analysis, a pivotal platform for researchers and practitioners in the domains of Statistics and Probability, as well as Modeling and Simulation. Published by Università del Salento in Italy, this journal has been dedicated to disseminating valuable insights and advancements in applied statistical methodology since its inception in 2008. With its ISSN of 2070-5948, the journal operates within an esteemed academic framework, contributing significantly to the field despite its current Q4 ranking in both Statistics and Probability and Modeling and Simulation categories as of 2023. As we continue to explore complex statistical models and simulation techniques, the journal encourages submissions that advance theoretical and practical understandings, inviting the global academic community to engage with transformative research endeavors. For those looking to stay informed and ahead in the dynamic world of applied statistics, the Electronic Journal of Applied Statistical Analysis is an essential resource.

Contemporary Clinical Trials Communications

Advancing Clinical Research for a Healthier Tomorrow
Publisher: ELSEVIER INCISSN: Frequency:

Contemporary Clinical Trials Communications, published by ELSEVIER INC, serves as a pivotal resource in the evolving fields of medicine and pharmacology, especially with its commitment to open access since 2015. With the E-ISSN 2451-8654, this journal is dedicated to disseminating high-quality research that examines contemporary clinical trial methodologies and their applications in improving healthcare outcomes. Situated in the United States, its impressive ranking, with a Q2 status in both Medicine (miscellaneous) and Pharmacology for 2023, highlights its significance and impact within the scientific community. Ranking #199 out of 636 in General Medicine and #217 out of 313 in Pharmacology on the Scopus scale, the journal aims to foster innovative discussions and developments among researchers, professionals, and students, making it an essential tool for those seeking to stay at the forefront of clinical research and trials.

STATISTICAL METHODS IN MEDICAL RESEARCH

Advancing statistical innovation for better health outcomes.
Publisher: SAGE PUBLICATIONS LTDISSN: 0962-2802Frequency: 6 issues/year

STATISTICAL METHODS IN MEDICAL RESEARCH is a leading academic journal dedicated to advancing the field of statistical methodologies as they apply to medical research. Published by SAGE Publications Ltd, this prestigious journal focuses on innovative statistical techniques that are pivotal for health-related data analysis and interpretation. With its Q1 ranking in Epidemiology, Health Information Management, and Statistics and Probability as of 2023, it stands out as a vital resource for researchers and practitioners alike. The journal, which has been in circulation since 1992, is widely recognized for its robust contributions to evidence-based medicine and public health, ensuring that practitioners have access to cutting-edge research. Although it currently does not offer Open Access options, the high-impact nature indicated by its rankings and percentile positions solidifies its importance as a go-to source for statistical theories and applications in health research. Researchers, healthcare professionals, and students are encouraged to explore the rich content of this journal to stay abreast of the latest advancements and methodologies.

Statistics in Biopharmaceutical Research

Elevating drug development through innovative statistical solutions.
Publisher: TAYLOR & FRANCIS INCISSN: 1946-6315Frequency: 4 issues/year

Statistics in Biopharmaceutical Research, published by Taylor & Francis Inc, is a premier journal that occupies a crucial space in the realms of Pharmaceutical Science and Statistics and Probability. With a robust impact factor affirmed by its Q1 rankings in both categories, the journal stands as a beacon for innovative statistical methodologies and their applications in biopharmaceutical research. Researchers and professionals will find a rich repository of high-quality articles that address contemporary challenges in drug development, clinical trials, and regulatory frameworks. Since its inception in 2011, the journal has continued to foster interdisciplinary collaboration, making significant strides towards enhancing statistical practice in biomedicine. With a commitment to academic rigor and practical relevance, Statistics in Biopharmaceutical Research is an essential resource for anyone looking to advance their understanding and application of statistical techniques in the pharmaceutical industry.

Clinical Trials

Driving progress in medicine with impactful studies.
Publisher: SAGE PUBLICATIONS LTDISSN: 1740-7745Frequency: 6 issues/year

Clinical Trials, published by SAGE Publications Ltd, is a prestigious journal that serves as a vital resource for researchers, professionals, and students in the fields of medicine and pharmacology. Operating since 2004 and converging through 2024, this journal boasts an impressive standing in the academic community, achieving a Q1 categorization in both Medicine (miscellaneous) and Pharmacology as of 2023. The journal's Scopus rankings reflect its influential contributions, with a rank of #128 out of 636 in General Medicine and a 79th percentile placement, alongside a rank of #172 out of 313 in Pharmacology, indicating its significant role in advancing clinical research. Based in the United Kingdom, Clinical Trials focuses on disseminating high-quality studies that enhance the understanding of clinical processes and therapeutic methodologies. Although it does not currently offer Open Access, the journal provides a platform for traditional publication, ensuring the dissemination of critical knowledge in the healthcare domain.

STATISTICS & PROBABILITY LETTERS

Delivering impactful research in statistics since 1982.
Publisher: ELSEVIERISSN: 0167-7152Frequency: 12 issues/year

STATISTICS & PROBABILITY LETTERS is a distinguished journal published by ELSEVIER, dedicated to advancing the field of statistics and probability. With an ISSN of 0167-7152 and an E-ISSN of 1879-2103, this journal is an essential platform for research, featuring cutting-edge studies and significant findings in the realms of statistical theory and applied probability. The journal operates under a notable Q3 ranking in both the categories of Statistics and Probability, and Statistics, Probability and Uncertainty for 2023, underscoring its relevance in these fields. Researchers, professionals, and students alike benefit from its rigorous peer-review process and its commitment to published integrity, fostering innovative insights from 1982 through its anticipated convergence in 2025. While it does not offer open access, the journal’s widely recognized impact within the academic community makes it a valuable resource for anyone seeking to deepen their understanding of statistical methodologies and probabilistic models.